Uterine Hemostasis Colloquium V

Uterine Hemostasis Colloquium V:
Hemostatic Disorders in Females with a Special Focus on Intrauterine, Fetal, and Neonatal Issues

Thursday, March 13^th, 2025 | Coronado, CA
Preceding HTRS Scientific Symposium 2025

Overview
The Foundation for Women and Girls⁺ with Blood Disorders is pleased to announce the 2025 national colloquium on uterine hemostasis. The Uterine Hemostasis Colloquium V will convene on the morning of Thursday, March 13^th, 2025 (preceding the HTRS Scientific Symposium at the Loews Coronado Bay Resort), where leading faculty, researchers, and clinicians will review the state of the science with respect to the management of placenta accreta, hematological disease of newborn, fetal and neonatal alloimmune thrombocytopenia, and fetal/neonatal hemostasis and thrombosis.

Learning Objectives

• Understand and discuss the processes related to blood clotting in fetuses and newborns
• Discuss and describe the potential maternal, fetal and neonatal consequences of placenta accreta, red blood cell (RBC) alloimmunization, Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), and the considerations professionals must address in making decisions regarding their management
• Select the appropriate diagnostic tests for evaluation of placenta accreta spectrum, RBC alloimmunization, and FNAIT to ensure timely and accurate diagnosis
• Describe new, effective approaches and available options for optimally managing care in pregnancies identified to be at-risk
• Describe how the intersection of obstetrics and hematology augments care coordination and fetal, neonatal, and maternal outcomes
• Discuss opportunities and strategies for provider training and support in the conduct of complex obstetric and hemostatic issues

Register Here Agenda

$75 registration fee for all attendees.
Register as a part of the overall HTRS 2025 Scientific Symposium.

---